School of Medicine
Showing 151-200 of 245 Results
-
Alphonsus Yun Xin Yip
Postdoctoral Scholar, Dermatology
BioDr Alphonsus Yip is a Postdoctoral Research Scholar in the Department of Dermatology at Stanford University and the Stanford Center for Digital Health, mentored by Eleni Linos. His research focuses on dermatology, artificial intelligence, and digital health, with an emphasis on personalized care and remote monitoring. Previously, he trained as a Clinical Research Fellow at St John’s Institute of Dermatology, contributing to clinical trials, digital tool evaluation, and NLP-based analyses of patient experiences in atopic dermatitis. At Stanford, he leads a national survey on healthcare professionals’ perspectives on AI and collaborates on AI-driven approaches for pediatric and rare skin disease detection.
-
Paul Yock, MD
Martha Meier Weiland Professor in the School of Medicine and Professor of Bioengineering, Emeritus
Current Research and Scholarly InterestsHealth technology innovation using the Biodesign process: a systematic approach to the design of biomedical technologies based on detailed clinical and economic needs characterization. New approaches for interdisciplinary training of health technology innovators, including processes for identifying value opportunities in creating new technology-based approaches to health care.
-
Jeehyun Yoe
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsUncovering and reprogramming molecular circuits guiding tumor-immune interplay
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research lab focused on using large database analyses and novel scalable approaches to improve the quality of cardiovascular care. In her clinical practice, Dr. Yong performs complex percutaneous coronary interventions and transcatheter aortic valve replacements. She is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease. She serves as an Associate Editor for the Journal of the American College of Cardiology and leads the VA-Cardiovascular Trials Consortium. She has co-authored national guidelines and scientific statements, including the ACC/AHA/SCAI Coronary Revascularization Guidelines.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, followed by internal medicine residency at University of California, San Francisco and cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. -
Juwon Yoo
Affiliate, Radiation Oncology
Biojuwon.yoo@berkeley.edu
-
Audrey Yoon, DDS
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Yoon is a double board-certified sleep specialist with the Stanford Health Care Sleep Medicine Center. She is currently a Clinical Professor in the Division of Sleep Medicine in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
She uses her extensive orthodontic experience to diagnose and treat obstructive sleep apnea (OSA) in children and adults. Dr. Yoon specializes in surgical and non-surgical OSA treatments, such as miniscrew-assisted rapid palatal expansion (MARPE), distraction osteogenesis maxillary expansion (DOME), and maxillomandibular advancement (MMA). These procedures restructure the palate, nasal airway, or jaw to improve airflow.
Her research interests include modifying head and face growth to improve sleep-disordered breathing in children and creating customized appliances that help reshape bones in the mouth, jaw, and face over time. She has also studied genetic anatomical factors related to OSA. Dr. Yoon worked with Stanford Medicine researchers to develop a new DOME technique, and she established and proposed a surgery-first approach protocol for MMA. With this approach, doctors surgically reposition the jaw before starting orthodontic treatment. The surgery-first approach can reduce the amount of time patients need to undergo orthodontic treatment.
Dr. Yoon has published in many peer-reviewed journals, including Sleep, Sleep Medicine, the American Journal of Orthodontics and Dentofacial Orthopedics, and the American Academy of Pediatric Dentistry, and she has written numerous book chapters. She has presented to her colleagues all over the nation and the world, including those in Germany, Italy, Australia, Chile, Singapore and China. Her presentations have covered a range of topics, such as the latest techniques in craniofacial (head and face) growth modification.
Dr. Yoon is a founding co-president of the World Dentofacial Sleep Society. She established a dental sleep medicine specialty clinic in the Division of Sleep Medicine at Stanford University School of Medicine. She also established the Dental Sleep Medicine Clinic at the University of the Pacific and is currently a program director of the Pacific Ortho-Dental Sleep Medicine Fellowship Program. Dr. Yoon also serves on the board of directors for the California Sleep Society, Angle Orthodontists, and the Korean Association of Dental Sleep Medicine.
She is a diplomate of the American Board of Orthodontics and the American Board of Dental Sleep Medicine. -
Byung Chul Yoon, MD, PhD ("Jason")
Assistant Professor of Radiology (Veterans Affairs)
Current Research and Scholarly Interests1. Alzheimer Disease and amyloid-related imaging abnormalities (ARIA)
2. Low-intensity focused ultrasound (LIFU)
3. Ultrasound imaging -
Jong H. Yoon
Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMy research seeks to discover the brain mechanisms responsible for schizophrenia and to translate this knowledge into the clinic to improve how we diagnose and treat this condition. Towards these ends, our group has been developing cutting-edge neuroimaging tools to identify neurobiological abnormalities and test novel systems-level disease models of psychosis and schizophrenia directly in individuals with these conditions.
We have been particularly interested in the role of neocortical-basal ganglia circuit dysfunction. A working hypothesis is that some of the core symptoms of schizophrenia are attributable to impairments in neocortical function that results in disconnectivity with components of the basal ganglia and dysregulation of their activity. The Yoon Lab has developed new high-resolution functional magnetic resonance imaging methods to more precisely measure the function of basal ganglia components, which given their small size and location deep within the brain has been challenging. This includes ways to measure the activity of nuclei that store and control the release of dopamine throughout the brain, a neurochemical that is one of the most important factors in the production of psychosis in schizophrenia and other neuropsychiatric conditions. -
Luke Yoon, MD
Clinical Associate Professor, Radiology
BioLuke Yoon, MD, is a Clinical Associate Professor and Associate Chair of Faculty Well-being and Development in the Department of Radiology at Stanford University School of Medicine. Dr. Yoon is a radiologist specializing in body imaging and musculoskeletal imaging. A graduate of Yale College and Yale School of Medicine, Dr. Yoon completed his post-graduate training at Harvard affiliated hospitals: internal medicine internship at Brigham and Women’s Hospital, and radiology residency and fellowship at Massachusetts General Hospital. Prior to joining Stanford Radiology, Dr. Yoon worked as an attending radiologist at Brigham and Women’s Hospital, Singleton Associates, and Baylor College of Medicine. His clinical interests include physician well-being, cystic renal mass imaging, and liver mass classification.
-
Kyan Younes, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Younes is a fellowship-trained, board-certified neurologist and a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
His areas of expertise include the diagnosis and treatment of Alzheimer’s disease, frontotemporal dementia, primary progressive aphasia, Lewy body dementia, normal pressure hydrocephalus and cognitive and behavioral impairments. For each patient, Dr. Younes develops a personalized plan of care. A plan may include his close collaboration with experts from psychiatry, nursing, pharmacy, genetic counseling, and other specialties. His goal is to ensure that each patient receives care that is both comprehensive and compassionate.
To help lead advances and innovations in his field, Dr. Younes conducts extensive research. He is studying the clinical, neuropsychological, socioemotional, genetic, and pathological features when a patient experiences degeneration of the right anterior temporal lobe area of the brain. This disorder can affect a person’s ability to process emotions and person-specific knowledge.
He also is researching how multimodal brain imaging, including magnetic resonance imaging (MRI) and Positron Emission Tomography (PET) combined with machine learning can help improve the detection of neurodegenerative diseases. In other research, he has participated in clinical trials of new drug therapies for Alzheimer’s disease.
Dr. Younes has presented research findings at meetings of the American Neurological Association, American Academy of Neurology, and American Psychiatric Association. Topics have included predictors of cognitive performance in dementia.
He has co-authored research articles published in the American Journal of Psychiatry, Annals of Clinical and Translational Neurology, Journal of Neuroimaging, and elsewhere. Subjects of these articles have included guidelines for diagnosing the effects of right anterior temporal lobe degeneration on behavior, treatment for symptoms of encephalitis, and the impact of mild traumatic brain injury on healthy older adults.
Dr. Younes has written chapters on frontotemporal dementia for Psychiatric Clinics as well as the epilepsy, coma, acute ischemic stroke, meningitis and encephalitis chapters for the textbook The Little Black Book of Neurology.
He is a member of the American Academy of Neurology, American Neurological Association, Alzheimer’s Association, and International Society for Frontotemporal Dementias. -
Isabella Young
Affiliate, Psychiatry and Behavioral Sciences
BioIsabella “Bella” Young is a Clinical Psychology doctoral student in the PAU–Stanford Consortium, expected to graduate in 2030. She holds dual Bachelor of Science degrees in Psychology and Criminology, with minors in Sociology and Political Science, from the University of Utah, and earned her Master’s degree in Clinical Psychology from Teachers College, Columbia University.
Bella is committed to integrating empirical research with evidence-based treatment, believing this combination creates the most effective approaches to care. She is a proud alumna of the Perinatal Research on Intergenerational Solutions for Equity (RISE) Laboratory, where she contributed to the Nurse-Family Partnership and Mozambique studies, examining how social inequities become biologically embedded across generations through DNA methylation. She also partnered with Manhattan-based organizations advancing Birthing Justice.
Currently, she continues her work in Columbia’s Maternal & Reproductive Psych Laboratory, where she helped launch a Reproductive Identity study and served as first author on a reproductive identity narrative.
Her research interests focus on perinatal mood and anxiety disorders, reproductive identity, and severe personality pathology in mothers (e.g., borderline personality disorder, postpartum psychosis). Ultimately, Bella aspires to become a clinical psychologist dedicated to bridging research and clinical practice to better support individuals during the perinatal period. -
Peter A Young
MSPA Instructional Faculty, Physician Assistant Studies
BioAs a Visiting Scholar in the Department of Dermatology, I am fortunate to have world-class mentors and colleagues who are committed to a collaborative approach to research. Having a family history of melanoma, I am passionate about investigating skin cancers and other skin conditions. In 2022, I was named Dermatology PA of the Year by the Society of Dermatology Physician Assistants, a national organization with over 4,700 members.
I have co-authored 30 academic publications on a variety of topics including dermatologic surgery, rare skin conditions, allergen content of skin care products, and the state of diversity within the dermatology profession. My writing has appeared in the Journal of the American Medical Association, Journal of the American Academy of Dermatology, Cutis, and elsewhere. My work has also been cited in UpToDate- the world’s most widely used evidence-based encyclopedia for medical professionals.
Most importantly, I believe in exercising empathy and compassion, taking the time to listen to patients as if they were family. To me, there is no greater responsibility or privilege than to be trusted with another person’s health. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
